clinical trials for tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Tirzepatide for Weight Loss |

This makes it a triple agonist medication, the first of its kind

Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity

Thursday, June 25, 2026 | 4:005:00 PM EST | Virtual (Zoom) Hosted by Tricia Ryan, BA, BSc, MBA Ryan, Director of Membership Development, Baking Association of Canada Featuring expert speakers: Derrick Lichti, Founding Engineer & Chief Data Officer, RxFood Corporation.com Reid McEachran, International Marketing Manager, Ardent Mills Seats are limited

Oral semaglutide offers a needle-free alternative to injectable GLP-1 therapy for weight management

Keto all-in-one GLP-1 supplements claim weight loss benefits but aren't FDA-approved medications

Dizziness during GLP-1 therapy is a reported side effect that typically appears in the first weeks of treatment